Mortimer, Ian Charles

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
20 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mortimer, Ian Charles's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-13
S Sale
17,588 -14.5%
490.87
US$1,145,875 		17,588 -14.5% 490.87 US$1,145,875
2026-03-13 2026-03-09
S Sale
52,136 +0.9%
171.16
US$242,688 		52,136 +0.9% 171.16 US$242,688
2026-03-13 2026-03-09
S Sale
72,858 +13.1%
363.47
CA$3,647,239 		72,858 +13.1% 363.47 CA$3,647,239
2026-03-13 2026-03-09
S Sale
43,348 -39.1%
59.26
US$2,568,802 		43,348 -39.1% 59.26 US$2,568,802
2026-03-13 2026-03-09
S Sale
2,449 -29.0%
61.26
US$150,026 		2,449 -29.0% 61.26 US$150,026
2026-03-13 2026-03-09
S Sale
10,072 -54.4%
60.47
US$609,054 		10,072 -54.4% 60.47 US$609,054
2026-03-13 2026-03-09
S Sale
12,479 -40.3%
59.50
US$742,500 		12,479 -40.3% 59.50 US$742,500
2026-03-13 2026-03-09
S Sale
21,515 -78.2%
60.49
US$1,301,442 		21,515 -78.2% 60.49 US$1,301,442
2026-03-13 2026-03-09
S Sale
31,694 -53.5%
59.88
US$1,897,837 		31,694 -53.5% 59.88 US$1,897,837
2026-03-13 2026-03-09
S Sale
21,791 -26.9%
58.81
US$1,281,529 		21,791 -26.9% 58.81 US$1,281,529
2026-01-06 2026-01-02
S Sale
2,062 -25.6%
44.93
US$92,646 		2,062 -25.6% 44.93 US$92,646
2026-01-06 2026-01-02
S Sale
37,938 -82.5%
44.40
US$1,684,447 		37,938 -82.5% 44.40 US$1,684,447
2025-12-10 2025-12-08
S Sale
2,010 -25.1%
46.32
CA$93,103 		2,010 -25.1% 46.32 CA$93,103
2025-12-10 2025-12-08
S Sale
8,820 -52.4%
45.59
CA$402,104 		8,820 -52.4% 45.59 CA$402,104
2025-12-10 2025-12-05
S Sale
14,375 -46.1%
45.03
CA$647,306 		14,375 -46.1% 45.03 CA$647,306
2025-12-04 2025-11-28
S Sale
97 -0.3%
45.01
US$4,366 		97 -0.3% 45.01 US$4,366
2025-10-02 2025-10-01
S Sale
25,000 -44.4%
40.16
US$1,004,000 		25,000 -44.4% 40.16 US$1,004,000
2025-01-28 2025-01-27
S Sale
1,149 -3.5%
41.07
US$47,189 		1,149 -3.5% 41.07 US$47,189
2025-01-28 2025-01-27
S Sale
15,166 -32.6%
40.46
US$613,616 		15,166 -32.6% 40.46 US$613,616
2025-01-28 2025-01-24
S Sale
22,468 -41.8%
40.20
US$903,214 		22,468 -41.8% 40.20 US$903,214
2025-01-28 2025-01-23
S Sale
16,217 -34.1%
40.08
US$649,977 		16,217 -34.1% 40.08 US$649,977
2024-10-02 2024-09-27
B Purchase
200,000 +176.5%
0.42
CA$84,000 		200,000 +176.5% 0.42 CA$84,000
2023-05-26 2023-05-24
S Sale
1,407 -4.3%
41.49
US$58,376 		1,407 -4.3% 41.49 US$58,376
2023-05-26 2023-05-24
S Sale
13,179 -32.2%
41.37
US$545,215 		13,179 -32.2% 41.37 US$545,215
2023-05-26 2023-05-24
S Sale
17,069 -41.3%
41.44
US$707,339 		17,069 -41.3% 41.44 US$707,339